Confometrx - CA Santa Clara, Palo Alto 94306

Confometrx entered the industry of Commercial Biotechnical Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Brian Kobilka by calling (650) 424-9980 during business hours. You can also write to the business’ Single Location at 840 Chimalus Drive, Palo Alto, California CA 94306. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Confometrx
Representative: Brian Kobilka
Place of Business: 840 Chimalus Drive, Palo Alto, CA 94306
Contact Number: (650) 424-9980
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2002
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Confometrx is a company operating from Santa Clara, California providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Confometrx has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Brian Kobilka at (650) 424-9980 for related queries, or to locate its Single Location using the coordinates 37.414209,-122.140137.

The Single Location can also be found at the street address 840 Chimalus Drive in Palo Alto, California 94306 and can be engaged online through the company website at , the company Twitter , and Facebook page .